0001628280-20-009293.txt : 20200611
0001628280-20-009293.hdr.sgml : 20200611
20200611173234
ACCESSION NUMBER: 0001628280-20-009293
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200610
FILED AS OF DATE: 20200611
DATE AS OF CHANGE: 20200611
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Skerlj Renato
CENTRAL INDEX KEY: 0001814632
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38295
FILM NUMBER: 20958113
MAIL ADDRESS:
STREET 1: C/O X4 PHARMACEUTICALS, INC.
STREET 2: 955 MASSACHUSETTS AVENUE, 4TH FLOOR
CITY: CAMBRIGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: X4 Pharmaceuticals, Inc
CENTRAL INDEX KEY: 0001501697
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 273181608
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 955 MASSACHUSETTS AVENUE
STREET 2: 4TH FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 857-529-8300
MAIL ADDRESS:
STREET 1: 955 MASSACHUSETTS AVENUE
STREET 2: 4TH FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
FORMER COMPANY:
FORMER CONFORMED NAME: Arsanis, Inc.
DATE OF NAME CHANGE: 20100920
4
1
wf-form4_159191113695970.xml
FORM 4
X0306
4
2020-06-10
0
0001501697
X4 Pharmaceuticals, Inc
XFOR
0001814632
Skerlj Renato
12 CROCKER CIRCLE
NEWTON
MA
02465
0
1
0
0
Chief Scientific Officer
Stock Option (right to buy)
8.69
2020-06-10
4
A
0
50000
0
A
2030-06-09
Common Stock
50000.0
50000
D
25% of the shares subject to the option shall vest on June 10, 2021, with the remainder vesting in equal installments of 2.0833% of the shares subject to the option on the last day of each successive month thereafter for a period of 36 months, subject to the Reporting Person continuing to provide services through each such date.
Derek M Meisner, attorney-in-fact
2020-06-11